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Summary.-The amount of embryonic antigens (EA) was estimated in 13 BALB/c
fibrosarcomata by in vitro cell mediated cytotoxicity of anti-embryo spleen cells and
by quantitative absorption of an anti-embryo antiserum. A direct relationship
between amount of EA and tumour growing capacity was found. EA were detected
also on fast dividing testicular cells. It is suggested that EA expression on tumour
cells is related to a cell membrane function controlling mitosis rather than to a
function specifically related to the neoplastic status. Tumour take of low doses of
2 EA-bearing sarcomata was found to be enhanced in anti-embryo immune BALB/c
mice in comparison with that in normal and anti-fibroblast immune mice.
THE PRESENCE of embryonic antigens
(EA) on tumours induced by different
agents has been demonstrated in various
animal species and it has been ascertained
that such antigens differ both from the
individual ones which characterize chemic-
ally induced ttumours (Baldwin, Glaves
and Vose 1972; Menard, Colnaghi and
Della Porta, 1973; Thomson and Alex-
ander, 1973) and from the cross-reacting
antigens carried by viral tumours (Ting
et al., 1972; Kurth and Bauer, 1973).
The function of EA on tumour cells is
not clear: it is not yet known whether they
are related specifically to neoplastic trans-
formation, and conflicting results on their
behaviour as transplantation antigens
have been reported. In anti-embryo
immune animals, both with virus and
with chemically induced tumours, either
no effect (Ting, Rodrigues and Herberman,
1973; Baldwin, Glaves and Vose, 1974), or
protection (Coggin et al., 1971; Le Mevel
and Wells, 1973), or even enhancement
(Castro et al., 1973) have been reported.
In a previous experiment (Menard et
al., 1973) we demonstrated that expression
of EA on DMBA induced murine fibro-
sarcomata increased during serial trans-
plant in syngeneic host. In the present
study, we investigated (1) the correlation
between the amount ofEA and the growth
rate of sarcomata induced by different
agents, (2) the specificity of EA ascertain-
ing whether they can be demonstrated on
cells other than tumoral or embryonic
ones and (3) the influence of anti-embryo
immunity on tuimour growth.
MATERIALS AND METHODS
Mice. BALB/c, C3Hf and C57BL mice
of both sexes, maintained in this laboratory
by brother x sister mating, were used.
Where immunodepressed animals w%ere need-
ed, adult BALB/c mice w-ere thymectomized
and total body irradiated 24 h later (450 rad).
Tuanours. Fibrosarcomata were induced
in BALB/c mice by subcutaneous implanta-
tion of a teflon disc 15 mm in diameter, by
a single subcutaneous injection of 50 ,ug of
7,12-dimethylbenz(a)anthracene (DMBA) in
oil suspension, by exposing to 3-methyl-
cholanthrene (MCA) BALB/c normal fibro-
blasts in diffusion chambers inserted in the
abdominal cavity of BALB/c mice (Parmiani,
Carbone and Lembo, 1973), and by sponta-
neous transformation of BALB/c normal
fibroblasts in in vitro long-term culture
(Carbone, Piazza and Parmiani, 1974). Each
tumour w%as maintained by serial subcu-
taneous passage in syngeneic mice ofthe same
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sex as the tumour donor. In addition, a
lymphosarcoma named C57LyUr24, origin-
ally induced in the thymus ofa C57BL mouse
by urethane and since then kept by subcu-
taneous transplants in C57BL mice, was used.
This lymphoma was demonstrated to bear
EA and served as source ofstandard reference
cells for anti-embryo C57BL antisera.
Imm4nizations.-Cell suspensions were
obtained mechanically from 10- to 14-day old
C3Hfembryos or by trypsinization from new-
born C3Hffibroblasts. The cells were block-
ed byincubation for 3 h at37°C in Mitomycin-
C, 250 ,-tg/10 x 106 cells in 2 ml of Hanks'
balanced salt solution (HBSS), and washed
repeatedly before injection. Immunizations
were carried out in adult BALB/c males by
5 weekly injections half subcutaneously (s.c.)
and halfintraperitoneally (i.p.) with two-fold
increased doses, the first dose being 2 x 106
cells.
Microplate technique for cell mediated cyto-
toxicity.-The test was carried out following
a previously described technique (Menard,
Pierotti and Colnaghi, 1972). Briefly, fibro-
sarcoma cells obtained by trypsinization from
the in vivo transplant were cultured in Falcon
flasks (No. 3024) for 1 week in medium 199
supplemented with 20% heat inactivated
foetal calf serum, streptomycin (100 ,ug/ml)
and penicillin (100 i.u./ml). The cells were
then removed by trypsinization and labelled
with 51Cr by incubating 20 x 106 cells in 1 ml
HBSS with 200 ,ug 51Cr (Radiochemical
Centre, Amersham, England) for 3 h at 370C.
After repeated washing, 104 labelled cells
were seeded in each well ofFalcon microplate
II (No. 3040) and incubated for 24 h at 370C
in an atmosphere of 5% CO2. Then in each
well containing the labelled target cells,
20 x 106 effector cells, obtained from spleen
of normal or immune mice, were seeded and
the plates were incubated for other 24 h.
The surnatant ofeach well was thenharvested
and each well washed 3 other times with
HBSS. The surnatants were then counted
in a y counter.
The percentage of specific 51Cr release was
calculated as follows:
(experimental release-control release)
(total label-control release) x 100
Antisera absorption procedure and cyto-
toxic test.-Absorbing cells were prepared
mechanically from in vivo transplanted fibro-
sarcomata, from BALB/c newborn fibro-
blasts, from testicles of prepubescent 18-day
old or adult C57BL mice and from normal
thymuses of adult C57BL mice. The tissues
were minced gently by scissors in HBSS and
the cell suspensions obtained were washed
repeatedly. The cells, in the proper doses,
were then distributed in small test tubes and
centrifuged to remove the surnatant; then the
packed cells were added with 0.1 ml of heat-
inactivated antiserum from C57BL mice
immuneagainstC3Hfembryocells, undiluted,
in one experiment, or diluted to give approxi-
mately 60% mortality on the syngeneic
lymphoma C57LyUr24. The various sam-
ples containing 5, 15 or 45 x 106 absorbing
cells were incubated for 20 min at 37°C and
for 60 min at 4°C and then centrifuged; the
surnatants were tested for remaining cyto-
toxicity against the C57LyUr24 reference
cell. The labelling of the lymphoma cells
was obtained by incubating 20 x 106 cells in
1 ml of HBSS with 150 ,uCi 51Cr at 37°C for
30 min. The labelled cells were washed 4
times with HBSS, adjusted to 10 x 106
cells/ml, then 0-025 ml of the test serum was
incubated with 25 x 104 cells at 37°C for 30
min. The serum was then discarded by
centrifugation and 0-025 ml of guinea-pig
complement diluted 1 : 4 was added. After
a 30 min incubation at 37°C, 2 ml of HBSS
was added, the tubes were centrifuged and
1 ml of the supernatant was measured in a
counter. The percentage of specific 51Cr
release was calculated as described for the
51Cr test for cellular cytotoxicity.
Tumour growth evaluation.-The growing
capacity of the various fibrosarcomata was
evaluated in immunodepressed mice by
considering two different parameters: the
number of cells for obtaining 50% tumour
take and the tumour growth rate. Ten-fold
increased doses between 101 and 105 cells of a
tumour cell suspension prepared mechanic-
ally in HBSS were injected s.c. in groups of
5-10 BALB/c mice. The mice were exam-
ined twice weekly and 2 diameters of the
tumours were measured. The number of
cells with 50% tumour take was extrapolated
from the curve of tumour incidence at the
various cell doses. The growth rate was
calculated as the mean number of days from
injection of 104 cells to a tumour of a mean
diameter 10 mm.
In vivo challenge.-The growth of 2
DMBA-induced fibrosarcomata (No. 1 and 2),
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at the 15th and the 10th transplant genera-
tion respectively, was tested in BALB/c mice,
untreated or immunized as above described,
against embryo or fibroblastic cells. Animals
were challenged on the opposite flank to that
of immunization, 7 days after the last
immunizing inoculum. All mice were exam-
ined 3 times weekly and 2 tumour diameters
were measured. Tumour volume was calcu-
lated by the formula: A x B2 x 04, A being
the larger and B the smaller diameter.
RESULTS
Amount of EA
The amount of EA in different fibro-
sarcomatawas estimated by measuring the
cytotoxic activity of anti-embryo spleen
cells on the fibrosarcoma cells, and the
absorbing capacity of fibrosarcoma cells
for an anti-embryo serum. The results are
reported in the Table. Ten of the 15
cytotoxic tests on 13 fibrosarcomata were
positive, the immune lymphocytes giving
a specific 51Cr release of over 20%. The
3 spontaneous tumours tested and 2 out of
5 teflon induced tumours were positive
even at the early transplant generation,
when the 2 tumours induced by chemical
carcinogens were negative. Two of the 5
negative tumours were tested again at
later transplants and found positive, as
were 3 additional chemically induced
tumours tested after more than 10
passages. Control lymphocytes sensitized
against adult fibroblasts were tested on
the same fibrosarcoma target cells and
never found to be cytotoxic. Pertinent
data are therefore not reported in the
Table.
Nine of the 13 fibrosarcomata were
studied for their capacity to absorb the
activity of the C57BL anti-embryo anti-
serum. The 3 fibrosarcomata which had a
43-57% specific 51Cr release when chal-
lenged with anti-embryo lymphocytes,
absorbed more than 80% of the cytotoxic
activity of the anti-embryo serum even at
5 x 106 cells, whereas the 2 fibrosarco-
mata with a 32-39% release caused 50%
absorption at the same dose of absorbing
cells. Three fibrosarcomata which were
negative in the cell mediated test absorbed
little of the activity of the anti-embryo
TABLE.-Amount of Embryonic Antigens and Growth ofBALB/c Fibrosarcomata,
Spontaneous or Induced by Chemical or Physical Agents
Amount of embryonic antigens
Inducing agent
and tumour
number
DMBA 1
DMBA 2
DMBA 3
Teflon 3
Teflon 4
Teflon 7
Teflon 9
Teflon 11
MCA 1
MCA 2
Spontaneous 1
Spontaneous 2
Spontaneous 3
No. of
tumour
passages
23
6
20
18
1
10
1
1
3
13
3
3
2
% Specific
5'Cr release
with
anti-embryo
lymphocytes'
43
6
56
57
12
50
46
7
32
2
5
40
30
32
39
% Reduction of C57BL anti-
embryo serum activity after
absorption with tumour cells
5 x 106 15 x 106 45 x 106
81 87 90
50 81 76
NT3 NT NT
91 92 90
8 19 27
NT NT NT
88 89 89
32 64 60
NT NT NT
NT NT NT
23 23 64
NT NT NT
NT NT NT
54 69 73
50 62 NT
1 Tests with a specific 5'Cr release 20% were considered positive.
2 In immunodepressed mice.
3 NT = Not tested.
Tumour growth2
No. of days
No. of cells from injection
for 50% to a 10 mm
tumour take tumour
101.8 20
102.7 26
100.8 15
101.5 18
104.0 56
100.5 14
100- 6 15
102.5 20
102.8 27
104-0 45
103-0 28
101.5 21
102.4 24
101.5 25
102.5 21
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antiserum even at the highest dose ofcells.
Normal fibroblasts never absorbed more
than 25% of the serum activity even at
45 x 106 of cells.
Tumour growth in immunodepressed mice
As reported in the Table, there was a
direct relationship between the 2 para-
meters selected to define the growing
capacity of the 13 fibrosarcomata, since
the fewer the cells needed to reach 50%
tumour take, the faster was tumour
growth. Two fibrosarcomata, as in the
cytotoxic study, were tested both at early
and late transplant generations and were
found to increase their growing capacity
after serial transplantation.
Correlation between tumour take and anti-
embryo cytotoxicity and nature of EA
A comparative analysis of the data
reported in the Table reveals that the
tumours with a higher expression of EA
had also a higher growing capacity. In
particular, as depicted in Fig. 1, the lower
the dose ofcells required for a 50% tumour
take, the more positive was the tumour for
EA, as tested by the immunosensitivity of
tumour cells to anti-embryo spleen cells.
This observation suggested that EA are
expressed in higher quantity in faster
dividing cells. To test this hypothesis,
the anti-embryo serum was absorbed with
cells obtained from testicles of 18-day old
or adult mice. In the cell suspension of
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FiG. 1.-Relationship between tumour take in immunodepressed mice and expression of embryonic
antigens of 15 fibrosarcomata.
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FIG. 2. Absorption of an anti-embryo antiserum with thymus cells from adult mice (dotted column),
or testicular cells from adlult mice (white column) or from 18-day old mice (black column). Un-
absorbed serum (shade(d column) gave 30% specific cytotoxicity on the C57LyUr24 reference cell.
the prepubescent testicles only the fast
dividing spermatogonia were observed
whereas in that of adult testicles sperma-
tozoa were also present. As shown in
Fig. 2, both types of cell suspension com-
pletely absorbed the serum activity while
the control thymus cells were ineffective.
Tumour growth in immaune mice
The 2 DMBA induced fibrosarcomata
tused in the challenge experiment were
chosen from those shown to bear EA and
not to grow in normal untreated mice at
low doses of tumour cells, allowing detec-
tion of an enhancement phenomenon.
As shown in Fig. 3, when anti-embryo
immune mice were injected with low doses
oftumour cells obtained from either ofthe
2 fibrosarcomata, the tumour take was
higher than in normal or anti-fibroblast
immune mice. However, when for one of
the tumours a higher dose ofcells was used
for challenge, the tumour took similarly in
all 3 groups but the growth rate was
slower in mice immune to embryo cells
than in those immune to fibroblastic cells
or in untreated mice (Fig. 4).
DISCUSSION
Our present results show that the
expression ofEA on tumour cells can vary
widely and confirm our previous data
(Menard et al., 1973), indicating an
increased amount of EA with serial
transplantation passages. The 3 sponta-
neous tumours and 2 of the 5 fibrosar-
comata induced by a teflon disc were
found sensitive to the anti-embryo lym-
phocyte activity even at the early trans-
plant generations, therefore showing a
higher expression of EA than the chemic-
ally induced tumours. The tests we used
to estimate the amount of EA, i.e. direct
cell mediated cytotoxicity and absorption
of an anti-embryo antiserum, can give
only an approximate evaluation, which
was found, however, to be similar for
both tests.
The amount of EA was found to
correlate with the growing capacity of the
tumours and seems, therefore, to run
parallel to the dividing rate of the tumour
cells. In fact, the absorbing capacity of
the tumour cells for the anti-embryo
antiserum was comparable with that of
- A---d b-i-
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FIG. 3. Per cent of tumour take after challenge with 2 DMBA-induced BALB/c fibrosarcomata in
BALB/c mice untreated (0 O), or immunized against allogeneic adult fibroblasts ( 0)
or embryo cells (A A); 9-10 animals per group.
rapidly dividing testicular cells either of
prepubescent or of adult mice. It should
be noted that in the former case no mature
spermatozoa known to bear EA (Artzt
et al., 1973) were present.
Other EA found in human and animal
systems also correlate to mitotic activity:
x-foetoprotein and CEA have been dernon-
strated not only in embryos or tumours
but also in regenerating lesions ofthe liver
and of the digestive tract (Abelev, 1971;
Laurence and Munro Neville, 1972); a
common factor has been observed in the
serum of pregnant or tumour bearing or
scalped rats (Tyndall et al., 1972); a
common antigen has been recently found
in murine mammary carcinoma and in
pregnant and lactating mammary glands
but not in normal ones (Bertini, Forni and
Comoglio, 1974). It seems therefore that
EA can be defined as cell cycle antigens.
Further studies on synchronized cells have
been planned to confirm this hypothesis.
It should be noted that the correlation
between membrane antigen expression
and cell cycle phases has been the subject
of several studies on different models
using different techniques with contrasting
results (Cikes and Friberg, 1971; Lerner,
Oldstone and Cooper, 1971; Pellegrino
et al., 1972; Killander, Klein and Levin,
1974).
The role of EA expression in and its
effects on tumour cells are not clear.
When tumour cells were injected in mice
previously immunized against embryo
cells, the take ofa small number oftumour
cells was higher than in untreated mice or
]
I
529530 S. MENARD, M. I. COLNAGHI AND G. DELLA PORTA
1500
E~~~~~~~~
E~~~~~~~
1000
x 0
l~ ~ ~ ~
co
25 30 35 40
DAYS AFTER CHALLENGE
FIG. 4. Size of fibrosarcomata DAIBA-2 in BALB/c mice untreated ( 0- O) oI immunized against
allogenieic a(lult fibroblasts (0 0*) or embryo cells (A A). Challenge with 5 x 103 tumour
cells.
mice immutnized against normal fibro-
blasts. At a higher cell dose the tumour
incidence was the same in the 3 groups,
although a decrease oftumour growth rate
was observed in anti-embryo immune
mice. This seems to indicate that en-
hancement and resistance depend on the
ratio between the level of immunity and
the amount ofantigen. It has been shown
that a mild degree of immunity may
enhance tumour growth (Prehn andLappe,
1971). In our experiment a high anti-
body-antigen ratio seems to stimulate
tumour growth whereas an increased
amount of antigen failed to enhance or
even afford detectable protection.
It is noteworthy that enhancement of
MCAinducedtumoursbyananti-allogeneic
embryo presensitization has already been
reported in BALB/c mice (Castro et al.,
1973) and that attempts to obtain an
active anti-embryo antiserum in the same
strain of mice were unsuccessful (Ting,
Ortaldo and Herberman, 1973). Converse-
ly, in C57BL mice the anti-embryo
immunity resulted in protection against a
MCA induced tumour bearing a strong
tumour transplantation antigen (Le Mevel
and WVells, 1973). The conflicting results
obtained with BALB/c or C57BL mice
may be due to genetically determined
balance between antibody and antigen or
to the fact that the response to strong
individual antigens may hamper the
expression of the enhancing phenomenon.
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